Logo

BCCA Purchases RainDance Platform for Cancer Predisposition Gene Sequencing

Nov 17, 2011
Premium

The British Columbia Cancer Agency has purchased RainDance Technologies' ThunderStorm microdroplet PCR platform for use in its Clinical Diagnostic Genomics group, the company said this week.

According to RainDance, over the next two years, BCCA researchers plan to sequence cancer predisposition genes in more than 2,000 samples from patients with a hereditary predisposition to various types of cancer. The researchers want to use that data to guide clinical management.

Filed under

Clinical Sequencing
Sequencing
Diagnostics
BC Cancer Agency
Bio-Rad
Breaking News
The Scan

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.